Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on MDRX. StockNews.com cut shares of Allscripts Healthcare Solutions from a "buy" rating to a "hold" rating in a research report on Friday, May 13th. The Goldman Sachs Group began coverage on shares of Allscripts Healthcare Solutions in a research report on Tuesday, July 12th. They issued a "neutral" rating and a $21.00 price objective for the company. Piper Sandler lowered their price objective on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 in a research report on Thursday, June 9th. Finally, TheStreet cut shares of Allscripts Healthcare Solutions from a "b" rating to a "c" rating in a research report on Friday, May 6th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Allscripts Healthcare Solutions currently has a consensus rating of "Hold" and a consensus price target of $21.80.
Allscripts Healthcare Solutions Trading Up 13.5 %
Allscripts Healthcare Solutions stock traded up $2.08 during midday trading on Friday, hitting $17.53. 3,122,237 shares of the stock were exchanged, compared to its average volume of 1,055,445. The company has a fifty day simple moving average of $15.57 and a two-hundred day simple moving average of $18.82. Allscripts Healthcare Solutions has a 52 week low of $13.05 and a 52 week high of $23.25. The stock has a market capitalization of $2.03 billion, a PE ratio of 40.77, a P/E/G ratio of 1.60 and a beta of 1.02. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 0.28.
Allscripts Healthcare Solutions (NASDAQ:MDRX - Get Rating) last released its quarterly earnings data on Thursday, August 4th. The software maker reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.03. Allscripts Healthcare Solutions had a net margin of 5.90% and a return on equity of 10.24%. The business had revenue of $150.90 million for the quarter, compared to analyst estimates of $148.58 million. During the same quarter last year, the firm earned $0.17 EPS. Allscripts Healthcare Solutions's quarterly revenue was up 6.9% compared to the same quarter last year. Equities research analysts anticipate that Allscripts Healthcare Solutions will post 0.67 EPS for the current fiscal year.
Insider Buying and Selling
In related news, insider Thomas Langan sold 51,537 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Tuesday, May 10th. The shares were sold at an average price of $18.12, for a total transaction of $933,850.44. Following the transaction, the insider now owns 139,912 shares of the company's stock, valued at approximately $2,535,205.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Allscripts Healthcare Solutions news, insider Thomas Langan sold 51,537 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Tuesday, May 10th. The shares were sold at an average price of $18.12, for a total value of $933,850.44. Following the transaction, the insider now owns 139,912 shares of the company's stock, valued at $2,535,205.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Richard J. Poulton sold 10,000 shares of Allscripts Healthcare Solutions stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $17.94, for a total transaction of $179,400.00. Following the completion of the transaction, the chief executive officer now directly owns 761,674 shares in the company, valued at approximately $13,664,431.56. The disclosure for this sale can be found here. Insiders have sold 318,015 shares of company stock valued at $5,550,054 in the last 90 days. 2.29% of the stock is owned by insiders.
